RossKeene

Of Counsel

上海 + 86.21.2201.8010

聯絡

*Share

Ross Keene has extensive experience advising clients from North America, Europe, Asia, and Australia on cross-border mergers and acquisitions, foreign direct investment, and commercial transactions relating to China. He has been based in China for more than 14 years, during which time he has represented clients in a number of sectors including financial services, real estate, energy and resources, life sciences, technology, infrastructure, and manufacturing. Ross also advises Chinese state-owned and private companies on their overseas acquisitions and other projects in Australia and other parts of the world.

Ross's representative transactions include advising: a sovereign wealth fund as part of the consortium that acquired ASX-listed Asciano Limited for A$9.05 billion; a Chinese state-owned enterprise on litigation related to its investment in a listed coal exploration company; a number of foreign investors on their acquisition and servicing of distressed assets in China; a number of global real estate developers and financial institutions on the acquisition, operation, and sale of a range of residential, retail, industrial, and mixed-use real estate projects in China; and Chinese and international resources companies on projects in Africa, Australia, and China.

Ross was previously chief representative of the Shanghai office of another international law firm. He also practiced in Singapore and for more than five years in Melbourne, where he advised clients on banking and finance, M&A, and resources projects in Australia and Asia.

Ross has extensive experience drafting and negotiating transaction documents in English and Chinese.

執業經驗

  • Sanofi to separate its consumer healthcare business, OpellaJones Day is acting as securities law counsel to Sanofi in the separation of Opella, its consumer healthcare business, and the announced sale of a 50% controlling stake.
  • Gaw Capital Partners enters strategic partnership with Sinar Primera in Indonesia data center developmentWorking with local Indonesian counsel, Jones Day advised Gaw Capital Partners regarding its entry into a strategic partnership with Sinar Primera, a leading Indonesian developer of new economy real estate, to develop an Internet Data Center at Nongsa Digital Park in Batam, Indonesia.
  • Gaw Capital Partners acquires Florentia Village Guangzhou Outlet MallJones Day advised Gaw Capital Partners in connection with the acquisition by a fund under Gaw’s management, alongside additional coinvestment partners, of Florentia Village Guangzhou, a designer outlet mall in Guangdong, China.
  • PTTGC acquires allnex from AdventJones Day advised PTT Global Chemical Public Company Limited in the €4 billion acquisition of allnex Holding GmbH from Advent International.
  • Helios Technologies completes acquisition of assets of JoyonwayJones Day advised Helios Technologies, Inc. in the acquisition of assets related to the electronic control systems and parts business of Shenzhen Joyonway Electronics & Technology Co., Ltd and its related entities (collectively “Joyonway”).
  • Axion BioSystems completes sale of company to Summa EquityJones Day advised Axion BioSystems, Inc., a leading provider of MEA and impedance technology for single-cell analysis, in its sale of the company to Summa Equity.
  • Major pharmaceutical company arbitrates claims arising out of Chinese investmentsJones Day is representing a major pharmaceutical company in a Hong Kong International Arbitration Centre arbitration arising out of representations and warranties given in respect of the client's investment in a Chinese drug development company whose senior officers and consultants were subsequently prosecuted in the United States for misappropriation of another pharmaceutical company's trade secrets.
  • U.S. design company conducts internal investigation into anonymous complaintsJones Day assisted a U.S. design company by conducting an internal investigation into anonymous allegations regarding the management and operations of the client's Chinese factory, including issues of conflicts-of-interest and corruption.
  • Greystar Asia Pacific forms Greystar China Multifamily Venture I LP with initial $450 million of commitmentsJones Day advised Greystar Asia Pacific Pte. Ltd. in connection with the formation of its first fund vehicle, Greystar China Multifamily Venture I LP, a Singapore-based fund that will acquire and develop multifamily real estate and real estate related assets in targeted cities in the Peoples Republic of China.
  • Lennox International sells refrigeration businesses in Australia, New Zealand, and Asia to Beijer Ref ABJones Day advised Lennox International Inc. in the sale of its refrigeration businesses in Australia, New Zealand, and Asia to Beijer Ref AB.
  • Glencore Singapore forms joint venture with Zhejiang Provincial PetroleumJones Day advised Glencore Singapore Pte. Ltd. on the formation of Zhejiang Petroleum Trading Co., Ltd., a joint venture with Zhejiang Provincial Petroleum Co., Ltd.
  • Pharmaceutical company successfully defends charge of commercial briberyA pharmaceutical company represented by Jones Day (in conjunction with local counsel) successfully challenged a charge of commercial bribery by a local branch of the Shanghai Administration of Industry and Commerce (AIC).
  • Newell Brands sells Winter Sports businesses to Kohlberg & Company for $240 millionJones Day advised Newell Brands Inc. (NYSE: NWL) in the sale of its Winter Sports businesses to private equity firm Kohlberg & Company for $240 million, subject to adjustment.
  • CIC Capital part of A$9.05 billion (US$6.75 billion) consortium for takeover of Asciano, one of the most complex transactions in Australia in recent times and largest deal in 2016Jones Day acted for CIC Capital Corporation on the A$9.05 billion (US$6.75 billion) takeover of rail and ports operator, Asciano, by a consortium including Brookfield, Qube Holdings, CPPIB, GIP, CIC Capital, GIC, Qatar Investment Authority, and bcIMC.
  • Wabtec acquires Gerken GroupJones Day advised Wabtec Corporation in its acquisition of Gerken Group SA, a leading manufacturer of specialty carbon and graphite products for rail and other industrial applications.
  • Ambrx and Hisun collaborate on development and commercialization of bispecifics for cancerJones Day represented Ambrx, Inc. in its collaboration with Zhejiang Hisun Pharmaceutical Company Ltd. for the development and commercialization of bispecifics based on Ambrx technology for the treatment of cancer.

    • The following represents experience prior to joining Jones Day.

    Energy and Resources
    Acted for Rio Tinto on its joint venture with Aluminum Corporation of China Limited in the Simandou iron ore project in Guinea, West Africa.

    Acted for a major international resources company on its investment in a port project in southern China.

    Acted for Oyu Tolgoi LLC in the Oyu Tolgoi copper gold project in Mongolia.

    Advised a major resources company on the divestment of its interest in an exploration joint venture in west China.

    Mergers and Acquisitions
    Acted for ANZ on its acquisition of a strategic interest in Shanghai Rural Commercial Bank and on the establishment of an outsourcing hub in Chengdu.

    Advised a U.S. financial services company on its proposed joint venture with a leading financial services state-owned enterprise.

    Advised a European pharmaceutical company on a raw materials manufacturing joint venture in China.

    Acted for Experian on its acquisition of 75 percent of the Emay group, a Chinese mobile marketing company.

    Advised Disney Interactive Studios on the acquisition of a Chinese games developer.

    Advised a Chinese state-owned enterprise on distribution arrangements for the Asia-Pacific region and on its entry into the Australian market.

    Acted for a number of large U.S. financial institutions on the formation of, and their exit from, real estate development joint ventures in various cities in China.

    Acted for Macquarie Bank on a number of real estate transactions in China including the sale of City Apartments, a 26-story tower of luxury apartments in downtown Shanghai.

    Advised Goodman on its $200 million joint venture with Canadian Pension Plan Investment Board and on a number of warehousing and logistics projects in China.

    Advised Concord Land on the acquisition and development of the Baccarat Residences in Shanghai.

    JULY 2024 Commentary

    China's Revised Company Law Introduces Significant Changes for Foreign Investors

    January 2024 White Paper

    Employee Stock Plans: International Reporting Requirements

    January 2023 White Paper

    Employee Stock Plans: International Reporting Requirements

    January 2022 White Paper

    2021 Transactional Year in Review and 2022 Forecast

    December 2021 White Paper

    Employee Stock Plans: International Reporting Requirements

    May 2020 White Paper

    Construction Projects and Disputes: A Look Beyond the COVID-19 Lockdown, Part II

    May 2020 White Paper

    Construction Projects and Disputes: A Look Beyond the COVID-19 Lockdown

    February 2020 Commentary

    China Further Opens its Market with New "Foreign Investment Law"

    August 2018 Commentary

    China Simplifies "Negative List" in Further Easing of Foreign Investment Restrictions

    May 2014 Commentary

    Recent Changes in the Registered Capital System in China
    顯示全部

    • 2013年11月15日
      中国企业海外投资的风险管控研讨会

    *Before sending, please note:

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.